The FDA will release a list of providers who received products from the New England Compounding Center in Framingham, Mass., which is at the center of a fungal meningitis outbreak that has killed nearly two dozen individuals.
The agency will release two lists of providers who received products from NECC after May 21. The first list includes customer names and addresses, organized by state. The second list contains the same basic information as the first list but is organized alphabetically by customer name and also includes the specific products shipped, the quantities of product shipped and the shipping date.
The FDA so far determined lots of methylprednisolone acetate are contaminated and are testing lots of triamcinolone acetonide and cardioplegic solution for potential contamination.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The agency will release two lists of providers who received products from NECC after May 21. The first list includes customer names and addresses, organized by state. The second list contains the same basic information as the first list but is organized alphabetically by customer name and also includes the specific products shipped, the quantities of product shipped and the shipping date.
The FDA so far determined lots of methylprednisolone acetate are contaminated and are testing lots of triamcinolone acetonide and cardioplegic solution for potential contamination.
More Articles on Patient Safety:
AAAASF Names Dr. Geoffrey Keyes Board President
Maintaining Quality at Pain Centers: Q&A With Dr. Edward Tavel of Pain Specialists of Charleston
C. Difficile Linked to Increased Length of Stay, Other Complications